CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
Helioxdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02135900
NCT02135900Phase 2Completed
CompareCT.gov

The Use of Heliox in Obstructive Sleep Apnea Syndrome.

Northwell Health·interventional·Posted May 12, 2014·Updated Jun 1, 2015

In Brief

A Phase 2 clinical trial evaluating Heliox for Obstructive Sleep Apnea Syndrome. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The goals of the project is to evaluate the effects of Heliox therapy on obstructive sleep apnea syndrome (OSAS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea Syndrome
CountriesUnited States
CollaboratorsStaten Island University Hospital

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 12, 2014
Enrollment StartDec 1, 2009
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.1 years ago

Interventions

Helioxdrug

From the onset of sleep until 2:00 am, patients will be placed on heliox 70/30. At 2:00 am patients will be switched to CPAP for titration according to American Academy of Sleep Medicine (AASM) guidelines.